Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii

Immunology

Volumn 123, Issue 4, 2008, Pages 469-479

  Fernandes, Karla Simone S ^a   Neto, Edward Helal ^b   Brito, Marcelly M S ^b   Silva, João S ^a   Cunha, Fernando Q ^a   Barja Fidalgo, Christina ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Fungus; Killing activity; Macrophages; Nitric oxide; Phagocytosis; Virulence

Indexed keywords

ARGININE DERIVATIVE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N OMEGA NITRO ARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPOROTHRIX SCHENCKII;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTOKINES; ENZYME INHIBITORS; IMMUNE TOLERANCE; INTERLEUKIN-10; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROARGININE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; SPOROTHRIX; SPOROTRICHOSIS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39549095810     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02712.x     Document Type: Article

References (54)

1. Morris-Jones R. Sporotrichosis. Clin Exp Dermatol 2002 27 : 427 31.
2. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. Ann Braz Acad Sci 2006 78 : 1 16.
3. Dickerson CL, Taylor RL, Drutz DJ. Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun 1983 40 : 417 20.
4. Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis 2001 7 : 134 6.
5. Carvalho MT, de Castro AP, Baby C, Werner B, Filus Neto J, Queiroz-Telles F. Disseminated cutaneous sporotrichosis in a patient with AIDS. report of a case. Rev Soc Bras Med Trop 2002 35 : 655 9.
6. Losman JA, Cavanaugh K. Cases from the Osler Medical Service at Johns Hopkins University. Diagnosis: P. carinii pneumonia and primary pulmonary sporotrichosis. Am J Med 2004 117 : 353 6.
7. Fernandes KS, Mathews HL, Lopes Bezerra LM. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J Med Microbiol 1999 48 : 195 203.
8. Fernandes KS, Coelho AL, Lopes Bezerra LM, Barja-Fidalgo C. Virulence of Sporothrix schenckii conidia and yeast cells and the susceptibility to nitric oxide. Immunology 2000 101 : 563 9.
9. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000 12 : 64 76.
10. Bocca AL, Hayashi EE, Pinheiro AG, Furnaletto AB, Campanelli AP, Cunha FQ, Figueiredo F. Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. J Immunol 1998 161 : 3056 63.
11. Martins GA, Vieira LQ, Cunha FQ, Silva JS. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun 1999 67 : 3864 71.
12. Nascimento FR, Calich VL, Rodriguez D, Russo MJ. Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. Immunology 2002 168 : 4593 600.
13. Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M. 1-tryptophan-l-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice. cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 2002 70 : 779 86.
14. Balish E, Warner TF, Nicholas PJ, Paulling EE, Westwater C, Schofield DA. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect Immun 2005 73 : 1313 20.
15. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006 21 : 12 20.
16. Green LC, Tannenbaum SR, Goldman P. Nitrate biosynthesis in germfree and conventional rat. Science 1981 212 : 56 68.
17. Schmidt H, Wilke P, Evers B, Bohme E. Enzymatic formation of nitrogen oxides from 1-arginine in bovine brain cytosol. Biochem Biophys Res Commun 1989 165 : 284 91.
18. + T cells and macrophages in acquired protection against Sporothrix schenckii in mice. Med Mycol 1999 37 : 397 404.
19. Carlos IZ, Sgarbi DB, Angluster J, Alviano CS, Silva CL. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 1992 117 : 139 44.
20. Carlos IZ, Zini MM, Sgarbi DB, Angluster J, Alviano CS, Silva CL. Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994 127 : 189 94.
21. Carlos IZ, Sgarbi DB, Placeres MC. Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. Mycopathologia 1999 144 : 9 14.
22. Carlos IZ, Sgarbi DB, Santos GC, Placeres MC. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol 2003 57 : 214 20.
23. da Silva AC, Bezerra LM, Aguiar TS, Tavares D, Araujo LM, Pinto CE, Ribeiro OG. Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect 2001 3 : 215 22.
24. Vogels MT, Hermsen CC, Huys HL, Eling WM, van Der Meen JM. Roles of tumor necrose factor-alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun 1994 62 : 2065 70.
25. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996 87 : 565 76.
26. Allendoerfer R, Deepe Jr. GS. Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol 2000 165 : 2657 64.
27. Souto JT, Figueiredo F, Furlanetto A, Pfeffer K, Rossi MA, Silva JS. Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol 2000 156 : 1811 20.
28. Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996 183 : 2533 40.
29. Calvo CR, Amsen D, Kruisbeek AM. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J Exp Med 1997 186 : 1645 53.
30. Ashkenzi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999 11 : 255 60.
31. Loweth AC, Williams GT, James RF, Scarpello JH, Morgan NG. Human islets of Langerhans express Fas ligant and undergo apoptosis in response to interleukin -1 beta and Fas ligation. Diabetes 1998 47 : 727 32.
32. Martins GA, Petkova SB, MacHado FS, Kitsis RN, Weiss LM, Wittner M, Tanowitz HB, Silva JS. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 2001 103 : 122 9.
33. Brown CY, Lagnado CA, Vadas MA, Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem 1996 271 : 20108 12.
34. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991 146 : 3444 51.
35. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991 147 : 3815 22.
36. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991 174 : 1549 55.
37. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 1992 182 : 1155 9.
38. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996 272 : 50 4.
39. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989 170 : 2081 95.
40. Del Sero G, Mencacci A, Cenci E et al. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1999 1 : 1169 80.
41. Michelin MA, Figueiredo F, Cunha FQ. Involvement of prostaglandins in the immunosuppression occurring during experimental infection by Paracoccidioides brasiliensis. Exp Parasitol 2002 102 : 170 7.
42. Sisto F, Miluzio A, Leopardi O, Mirra M, Boelaert JR, Taramelli D. Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei protective role of gamma interferon. Infect Immun 2003 71 : 465 73.
43. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004 172 : 3712 8.
44. Khan IA, Schwartzman JD, Matsuura T, Kasper LH. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A 1997 94 : 13955 60.
45. Wu-Hsieh BA, Chen W, Lee H. Nitric oxide synthase expression in macrophages of Histoplasma capsulatum-infected mice is associated with splenocyte apoptosis and unresponsiveness. Infect Immun 1998 66 : 5520 6.
46. Bocca AL, Silva MF, Silva CL, Cunha FQ, Figueiredo F. Macrophage expression of class II major histocompatibility complex gene products in Paracoccidioides brasiliensis-infected mice. Am J Trop Med Hyg 1999 61 : 280 7.
47. MacFarlane AS, Schwacha MG, Eisenstein TK. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 1999 67 : 891 8.
48. Van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001 1 : 1491 500.
49. Eisenstein TK. Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes Infect 2001 3 : 1223 31.
50. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995 375 : 408 11.
51. Koga T, Duan H, Furue M. Immunohistochemical detection of interferon-gamma-producing cells in granuloma formation of sporotrichosis. Med Mycol 2002 40 : 111 4.
52. Thomas SR, Mohr D, Stocker R. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J Biol Chem 1994 269 : 14457 64.
53. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 2001 69 : 5131 7.
54. Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii. induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 2002 70 : 859 68.